Type 2 diabetics now have another choice when it comes to their treatment. Along with the multiple choices of oral medication, a new injectable drug is now FDA approved and being prescribed. Being a type 2 diabetic myself, I can honestly say I would not be interested in another needle or two throughout the day. My fingers will thank me later! But for some diabetics, BYEETA has been the answer to their disease happiness.

Patients receiving BYETTA achieved a significant A1C reduction of 1.2% at Week 30 and 1.1% at 2.5 years1
Patients with a baseline A1C of …read more